Paradigm Biopharmaceuticals Ltd
F:P86
Paradigm Biopharmaceuticals Ltd
F:P86
Price:
0.0975
EUR
3.17%
Market Closed
Market Cap:
€41.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Paradigm Biopharmaceuticals Ltd
F:P86
|
AU |
|
V
|
Vislink Technologies Inc
OTC:VISL
|
US |
|
D
|
DBS Group Holdings Ltd
XMUN:DEVL
|
SG |
|
S
|
State Bank of India
F:SID
|
IN |
|
C
|
Conagra Brands Inc
XMUN:CAO
|
US |
|
R
|
Realtech AG
F:RTC
|
DE |
|
P
|
Pan American Silver Corp
XMUN:PA2
|
CA |
|
W
|
Westpac Banking Corp
XMUN:WBC
|
AU |
|
T
|
Thoresen Thai Agencies PCL
SET:TTA
|
TH |
|
F
|
Franklin Electric Co Inc
F:FE4
|
US |
|
Cherry SE
F:C3RY
|
DE |
|
Pattern SpA
MIL:PTR
|
IT |
|
R
|
Radian Group Inc
XMUN:RAG
|
US |
|
A
|
ADTRAN Inc
F:ATN
|
US |
|
S
|
Standard Chartered PLC
SWB:STD
|
UK |
Wall St Price Targets
P86 Price Targets Summary
Paradigm Biopharmaceuticals Ltd
Paradigm Biopharmaceuticals Ltd
Wall Street analysts forecast P86 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for P86 is 0.7836 EUR with a low forecast of 0.7759 EUR and a high forecast of 0.8066 EUR.
Lowest Forecast
Price Target
0.7759
EUR
696% Upside
Average Forecast
Price Target
0.7836
EUR
704% Upside
Highest Forecast
Price Target
0.8066
EUR
727% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is P86's stock price target?
Price Target
0.7836
EUR
0.7836
EUR
According to Wall Street analysts, the average 1-year price target for P86 is 0.7836 EUR with a low forecast of 0.7759 EUR and a high forecast of 0.8066 EUR.
What is the Revenue forecast for Paradigm Biopharmaceuticals Ltd?
Projected CAGR
185%
185%
Over the last 10 years, the compound annual growth rate for Revenue has been 99%. The projected CAGR for the next 3 years is 185%.
